The heavyweight division is finally making moves. Many think Jon Jones’ retirement will actually help the division grow. Now, Tom Aspinall is finally defending his championship belt against Ciryl Gane ...

Welcome to Advent Day 8! In today’s festive episode, we're diving into a special Christmas recipe that's sure to delight your taste buds this holiday season. Follow along as we guide you through each ...

SAN FRANCISCO, Sept 19 (Reuters) - Apple Watch Series 11 models that go on sale on Friday can notify users that they may have high blood pressure, in a feature the company has powered using artificial ...

Six months ago, Senate Minority Leader Chuck Schumer ignored a push by liberals to stand up to President Trump and shut down the government during a budget showdown. This time, Schumer and the ...

Listen to more stories on the Noa app. Sign up for Trump’s Return, a newsletter featuring coverage of the second Trump presidency. Immediately following the 2024 presidential election, Democrats ...

The University of Utah is roiled by a controversy surrounding two of the more-contentious aspects of campus life: course scheduling and parking. Starting in the spring, fewer courses will be offered ...

FARMINGDALE, N.Y. — The thing that people don’t get — that is, people who are not golf people — is that golf is about losing. You lose all the time and now and again you win. The reason Jack Nicklaus ...

IDAHO FALLS, Idaho (KIFI) — The United States government is bracing for a potential shutdown as a critical funding deadline looms at the end of tomorrow, with Congress deadlocked over a new spending ...

Jay primarily writes news and deals posts for Android Police. Before joining AP, he spent the past several years yammering on about the crazy world of Android for various tech outlets. Besides ...

President Trump had intensified pressure on the Justice Department in recent days, publicly demanding that top officials prosecute James Comey. Devlin Barrett Glenn Thrush and Alan Feuer Devlin ...

Emma Guttman, MD, PhD, discusses the promising potential of rocatinlimab in targeting the OX40-OX40 ligand pathway for atopic dermatitis treatment. Trial investigator Emma Guttman, MD, PhD, chair of ...